TALDO1

Transaldolase · P37837 · TALDO1 on Sugi Atlas →

0 patent compounds predicted against TALDO1, 0 high-confidence (nearest known ligand ≥ 0.5)

Top predicted compounds (top 20 by supporting neighbours, then confidence)

CompoundConfidenceSupporting neighbours

Clinical trials — most relevant to TALDO1 by text similarity (a relevance ranking, not an exhaustive list)

TrialPhaseStatus
Prevention of Renal Complications of Diabetes With Thiamine PHASE4UNKNOWN
Pioglitazone Study of Triglyceride Changes in Subjects With Type 2 Diabetes After Conversion From Rosiglitazone. PHASE4COMPLETED
Targeting de Novo Pyrimidine Biosynthesis by Leflunomide for the Treatment of COVID-19 Virus Disease PHASE3COMPLETED
Acetylcarnitine and Insulin Sensitivity PHASE2COMPLETED
Atorvastatin, L-Carnitine and Non-Alcoholic Steatohepatitis PHASE2UNKNOWN
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With a Novel Form of Anaplerosis PHASE2COMPLETED
To Assess Safety of Mitapivat and Provide Proof of Concept of the Efficacy of the Drug in Patients With RBC Membranopathies or CDAII. PHASE2RECRUITING
Vaccine Treatment for Advanced Non-Small Cell Lung Cancer PHASE1/PHASE2COMPLETED
Safety, Tolerability and Pharmacokinetics of Benfo-Oxythiamine (B-OT) in Healthy Volunteers PHASE1COMPLETED
A Phase 1b Study of the Safety of REN001 in Patients With Fatty Acid Oxidation Disorders PHASE1COMPLETED
Fatty Acid Oxidation Defects and Insulin Sensitivity nanCOMPLETED
Natural History and Advanced Genetic Study of Pyruvate Dehydrogenase Complex Deficiencies nanRECRUITING
Ataxia-telangiectasia: Treating Mitochondrial Dysfunction With Nicotinamide Riboside nanUNKNOWN
Influence of WNT4 VEZT FSHB and SIRT1 SNPs in Endometriosis: a Case Control Study of the Sardinian Population nanUNKNOWN
Genetic DAO Deficiency and Lower Urinary Tract Symptoms nanCOMPLETED
Genetic and Metabolic Disease in Children nanRECRUITING
Genetic Studies of Lysosomal Storage Disorders nanENROLLING_BY_INVITATION
Biomarkers in Exhaled Breath Condensates in Acute Lung Injury: Early Detection and Outcome Predictors nanUNKNOWN
Screening of IDH1 and IDH2 Gene Mutations in Adult Acute Myeloid Leukemia for Possible Targeted Therapy nanUNKNOWN
Fructose Supplementation in Carriers for Hereditary Fructose Intolerance nanCOMPLETED
High-Density Lipoprotein (HDL) Treatment Study nanCOMPLETED
Evaluation of a New Strategy for the Diagnosis of Peroxisomal Diseases nanCOMPLETED
Targeting zDHHC Enzymes to Counteract Alzheimer's Disease nanNOT_YET_RECRUITING
Treating Oxidative Stress and the Metabolic Pathology of Autism nanCOMPLETED
Study of Protein Translocation in Patients With Beta-Oxidation Disorders nanCOMPLETED
Glycine and Magnesium+Thiamine for the Treatment of Primary Ciliary Dyskinesia nanRECRUITING
Pathogenetic Basis of Aortopathy and Aortic Valve Disease nanACTIVE_NOT_RECRUITING
Polycystic Ovary Syndrome in Type 1 Diabetes nanNOT_YET_RECRUITING
Acute Nutritional Ketosis in VLCAD Deficiency nanCOMPLETED
The LD Lync Study - Natural History Study of Lipodystrophy Syndromes nanRECRUITING

Related proteins — ESM-2 sequence neighbours (a TALDO1 binder may also engage these)

ProteinNameSimilarity
Q9EQS0 1.000 Q9EQS0 →
Q93092 1.000 Q93092 →
Q2TBL6 1.000 Q2TBL6 →
Q8VI73 1.000 Q8VI73 →
B4F2V2 1.000 B4F2V2 →
P0A867 1.000 P0A867 →
P0A869 1.000 P0A869 →
Q142S4 1.000 Q142S4 →
Q6D0B2 1.000 Q6D0B2 →
Q29593 1.000 Q29593 →
B1ZUE6 1.000 B1ZUE6 →
A8FSH3 1.000 A8FSH3 →
B4E6F9 1.000 B4E6F9 →
B1J623 1.000 B1J623 →
Q602L8 1.000 Q602L8 →
Q3YZ89 1.000 Q3YZ89 →
B1JW82 1.000 B1JW82 →
Q2K414 1.000 Q2K414 →
P66955 1.000 P66955 →
P51778 1.000 P51778 →
A0K9A9 1.000 A0K9A9 →
Q07Z25 1.000 Q07Z25 →
Q9CKH9 1.000 Q9CKH9 →
B2J2D9 1.000 B2J2D9 →
Q48KH5 1.000 Q48KH5 →
A9AIJ8 1.000 A9AIJ8 →
Q884H4 1.000 Q884H4 →
Q57LN7 1.000 Q57LN7 →
P0A868 1.000 P0A868 →
A3N794 1.000 A3N794 →